Correction to: Development and validation of a modified albumin –bilirubin grade and α-fetoprotein score (mALF score) for hepatocellular carcinoma patients receiving atezolizumab and bevacizumab

Source: Hepatology International - Category: Infectious Diseases Source Type: research